These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20492398)
21. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139 [TBL] [Abstract][Full Text] [Related]
22. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate. Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385 [TBL] [Abstract][Full Text] [Related]
23. [The clinical application of sildenafil in porto pulmonary hypertension]. Shen YC; Wen FQ; Yi Q Zhonghua Jie He He Hu Xi Za Zhi; 2011 Sep; 34(9):691-3. PubMed ID: 22177497 [No Abstract] [Full Text] [Related]
24. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Madden BP; Sheth A; Wilde M; Ong YE Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500 [TBL] [Abstract][Full Text] [Related]
26. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist]. Micheletti A; Butera G; Chessa M; Carminati M Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861 [No Abstract] [Full Text] [Related]
27. Sildenafil in the management of the failing Fontan circulation. Reinhardt Z; Uzun O; Bhole V; Ofoe V; Wilson D; Onuzo O; Wright JG; Stumper O Cardiol Young; 2010 Oct; 20(5):522-5. PubMed ID: 20519058 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Noori S; Friedlich P; Wong P; Garingo A; Seri I Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates. Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001 [TBL] [Abstract][Full Text] [Related]
30. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery. Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396 [TBL] [Abstract][Full Text] [Related]
31. Sildenafil in older patients with secondary pulmonary hypertension. Minotti GC; Corsonello A; Incalzi RA J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072 [No Abstract] [Full Text] [Related]
32. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors]. Ghofrani HA; Grimminger F Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594 [TBL] [Abstract][Full Text] [Related]
33. Sildenafil in the management of primary pulmonary hypertension. Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929 [TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639 [TBL] [Abstract][Full Text] [Related]
35. Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: case report and review of the literature. Mercurio V; Carlomagno G; Fazio S Heart Lung; 2012; 41(5):512-7. PubMed ID: 22054725 [TBL] [Abstract][Full Text] [Related]
36. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children. Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543 [TBL] [Abstract][Full Text] [Related]
37. Potentiating the pulmonary vasodilatory effects produced by sildenafil. Dias-Junior CA Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734 [No Abstract] [Full Text] [Related]
38. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]. Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792 [TBL] [Abstract][Full Text] [Related]
39. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension. van Wolferen SA; Boonstra A; Marcus JT; Marques KM; Bronzwaer JG; Postmus PE; Vonk-Noordegraaf A Heart; 2006 Dec; 92(12):1860-1. PubMed ID: 17105892 [No Abstract] [Full Text] [Related]
40. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis]. Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]